Literature DB >> 16128371

QT dispersion and left ventricular hypertrophy in athletes: relationship with angiotensin-converting enzyme I/D polymorphism.

Halil Tanriverdi1, H Asuman Kaftan, Harun Evrengul, Dursun Dursunoglu, Günfer Turgut, Mustafa Kiliç.   

Abstract

BACKGROUND: QT dispersion (QTd) is a measure of inhomogeneous repolarization of myocardium and is used as an indicator of arrhythmogenicity. QTd is increased in myocardial hypertrophy secondary to systemic hypertension. The relation between left ventricular (LV) enlargement in endurance trained subjects and QTd is unknown. The cloning of the angiotensin-converting enzyme (ACE) gene has made it possible to identify a deletion (D)-insertion (I) polymorphism that appears to affect the level of serum ACE activity. The aim of this study was to assess whether physiologic left ventricular hypertrophy as a result of physical training is associated with an increased QT length or dispersion depending on ACE I/D polymorphism.
METHODS: 56 endurance athletes and 46 sedentary subjects were included in this study, and they underwent both complete echocardiographic and electrocardiographic examination, the QT interval was measured manually as an average based on a 12-lead ECG. We also analysed ACE I and D allele frequencies in all patients.
RESULTS: Athletes had a significantly increased LV mass (235.1 +/- 68.5 g vs. 144.9 +/- 44.5 g, p < 0.001) and corrected QTd (QTcd) (55.5 +/- 18.1 ms vs. 42.9 +/- 17.2 ms, p < 0.001) in comparison to control subjects. There was a positive correlation between left ventricular mass index and QTcd in athletes (r = 0.3, p = 0.024). Left ventricular mass and mass index in ACE DD, DI and II genotypes were significantly different (p < 0.001). QTcd was significantly different between ACE DD (63.2 +/- 12.8 ms) and ACE II (44.9 +/- 17.6 ms) genotypes in athletes (p < 0.05).
CONCLUSION: These data show that myocardial hypertrophy induced by exercise training might be associated with increased QTd as observed in systemic hypertension and might be affected by ACE I/D polymorphism.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16128371     DOI: 10.2143/AC.60.4.2004987

Source DB:  PubMed          Journal:  Acta Cardiol        ISSN: 0001-5385            Impact factor:   1.718


  6 in total

Review 1.  Is the 'athlete's heart' arrhythmogenic? Implications for sudden cardiac death.

Authors:  Thomas Rowland
Journal:  Sports Med       Date:  2011-05-01       Impact factor: 11.136

2.  Behavior of repolarization variables during exercise test in the athlete's heart.

Authors:  Annabella Braschi; Vincenzo C Francavilla; Maurizio G Abrignani; Lorenzo Todaro; Giuseppe Francavilla
Journal:  Ann Noninvasive Electrocardiol       Date:  2012-04       Impact factor: 1.468

3.  Effects of long-term physical activity on cardiac structure and function: a twin study.

Authors:  Sara Mutikainen; Merja Perhonen; Markku Alén; Tuija Leskinen; Jouko Karjalainen; Taina Rantanen; Jaakko Kaprio; Urho M Kujala
Journal:  J Sports Sci Med       Date:  2009-12-01       Impact factor: 2.988

Review 4.  Utility of genetic testing in athletes.

Authors:  Belinda Gray; Christopher Semsarian
Journal:  Clin Cardiol       Date:  2020-01-11       Impact factor: 2.882

Review 5.  Management of Congenital Long-QT Syndrome: Commentary From the Experts.

Authors:  Lee L Eckhardt; Elizabeth S Kaufman; Michael J Ackerman; Peter F Aziz; Elijah R Behr; Marina Cerrone; Mina K Chung; Michael J Cutler; Susan P Etheridge; Andrew D Krahn; Steven A Lubitz; Marco V Perez; Silvia G Priori; Jason D Roberts; Dan M Roden; Eric Schulze-Bahr; Peter J Schwartz; Wataru Shimizu; M Benjamin Shoemaker; Raymond W Sy; Jeffrey A Towbin; Sami Viskin; Arthur A M Wilde; Wojciech Zareba
Journal:  Circ Arrhythm Electrophysiol       Date:  2021-07-09

6.  A 24-hour ambulatory ecg monitoring in assessment of qt interval duration and dispersion in rowers with physiological myocardial hypertrophy.

Authors:  I Y Lutfullin; Z F Kim; R R Bilalova; N A Tsibulkin; R R Almetova; R R Mudarisova; I I Ahmetov
Journal:  Biol Sport       Date:  2013-11-25       Impact factor: 2.806

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.